1 / 16

Adherence to Antidepressant Medications Among Health Plan Members Diagnosed with Major Depression

Adherence to Antidepressant Medications Among Health Plan Members Diagnosed with Major Depression. Ayse Akincigil, John R. Bowblis, Carrie Levin, James T. Walkup, Saira Jan, Stephen Crystal AcademyHealth 2006 Annual Research Meeting Monday, June 26

pascale-frank
Télécharger la présentation

Adherence to Antidepressant Medications Among Health Plan Members Diagnosed with Major Depression

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Adherence to Antidepressant Medications Among Health Plan Members Diagnosed with Major Depression Ayse Akincigil, John R. Bowblis, Carrie Levin, James T. Walkup, Saira Jan, Stephen Crystal AcademyHealth 2006 Annual Research Meeting Monday, June 26 Supported in part through NIMH grant R01 MH60831, AHRQ grants U18 HS016097 and HS-01182, and a grant by Horizon BCBSNJ

  2. Background / Objectives There is a large amount of evidence that antidepressants are effective in reducing symptoms of depression and preventing relapse; however, poor adherence to medication is a major obstacle to effective care. We describe characteristics of patients at risk for low adherence, and implications for policy and practice.

  3. Methods • A retrospective, observational study of insurance claims. • A large insurance company in Northeast, serving three-million lives. • Data are constructed from insurance claims, between January 2003 and January 2005. • Pharmacy claims are used to construct the outcome measure -- refill persistence. • Medical claims are used to identify patients with a new episode of depression.

  4. Index prescription date Prescription look back period 90 days Medication window 30 14 Diagnosis look back period 120 days Index episode start date (Date of Depression Diagnosis) Study Population

  5. Outcome Measures Index prescription date Effective Acute Phase Treatment 114 days Effective Continuation Phase Treatment 231 days 30 14 Index episode start date

  6. Overall Rates of Refill Persistence

  7. Gender (67% female) Age 18-25 (11%) 25-39 (32%) 40-49 (28%) 50-64 (26%) 65 or older (4%) Demographic, Socio-Economic Characteristics • Median household income at the neighborhood (zip-code) • <50k (29%) • 50k-70k (42%) • >70k (29%)

  8. Alcohol Abuse (5%) Substance Abuse (8%) Anxiety Disorder (28%) Cancer (18%) Number of Cardiovascular Risk Factors (18% suffer from one, 6% suffer from 2 or more) Comorbid Conditions

  9. Type of Provider on Initial Visit (49% were mental health professional, 51% were general medical care). Initial antidepressant drug type (4% were on older generation drugs). 28% had a follow-up visit with a psychiatrist. 24% had a follow-up visit with another mental health provider (e.g., psychologists, social workers). Care Patterns for Depression Episode

  10. General Use of Health and Pharmacy Services

  11. Predictors of Refill Persistence in Acute Phase (1)

  12. Predictors of Refill Persistence in Acute Phase (2)

  13. Predictors of Refill Persistence in Acute Phase (3)

  14. Predictors of Refill Persistence in Acute Phase (4)

  15. Non-Adherence Risk Factors for 0-8 Months (Continuation Phase) • Males * • Younger age • Patients from low income neighborhoods • Comorbid substance abuse • Comorbid alcohol abuse • 2+ CVD Protective Factors • F/U care from a psychiatrist • Number of medications other than psychotropics

  16. Summary • Adherence rates are low, problem worsens in continuation phase. • Males, younger, and living in lower income neighborhoods are particularly at risk. • No support to the scenario of “medication crowd-out” among users of multiple medications. • Presence of multiple cardiovascular risk factors may crowd out depression. • Depression care for those with comorbid substance abuse and alcohol abuse are further complicated due to adherence issues. • Having a follow up with a psychiatrist improves odds of adherence. • Those who had follow up visits with social workers or psychologists were equally likely to adhere, compared to those with no follow up.

More Related